---
author: Harvey Guo
created: 2024-01-31 16:21
modified: 2024-01-31 16:21
aliases:
  - SERMs
  - SERM
  - Tamoxifen
  - Raloxifene
  - Clomiphene
share: true
---
# Tamoxifen
---
## Mechanism of action
- Competitive <span style="background:rgba(240, 200, 0, 0.2)">antagonist on the estrogen receptors of the breast</span> → ↓ [[breast cancer|breast cancer]] cell growth
- <span style="background:rgba(240, 200, 0, 0.2)">Agonist on estrogen receptors in the following tissues</span>:
	- Bone tissue → inhibition of [[Bone remodeling|osteoclasts]] → ↓ risk of [[osteoporosis|osteoporosis]] and fractures
	- Endometrium → ↑ proliferation
	- Myometrium → ↑ proliferation
## Indications
- <span style="background:rgba(240, 200, 0, 0.2)">Premenopausal estrogen receptor-positive [[breast cancer|breast cancer]]</span>
- Vaginal atrophy (related to [[menopause|menopause]])
- [[Prostate cancer|Prostate cancer]]: prevention of [[gynecomastia|gynecomastia]]
## Side effects
- Hot flashes
- <span style="background:rgba(240, 200, 0, 0.2)">↑ Risk of [[endometrial cancer|endometrial cancer]]</span>
- <span style="background:rgba(240, 200, 0, 0.2)">↑ Risk of [[Uterine leiomyoma#Uterine leiomyosarcoma (uterine sarcoma)|Uterine leiomyoma > Uterine leiomyosarcoma (uterine sarcoma)]]</span>
- <span style="background:rgba(240, 200, 0, 0.2)">↑ Risk of thromboembolic events (e.g., [[pulmonary embolism|pulmonary embolism]], DVT)</span>
	- Proposed mechanisms include increased levels of clotting factors (eg, prothrombin; fibrinogen; factor VII, VIII, X) and activated [[Inhibition of hemostasis|protein C]] resistance.
# Raloxifene
---
## Mechanism of action
- Competitive antagonist on estrogen receptors in the following tissues:
	- Breast → ↓ [[breast cancer|breast cancer]] cell growth
	- Endometrium and myometrium → ↓ proliferation<span style="background:rgba(240, 200, 0, 0.2)"> (in contrast to tamoxifen)</span>
- Agonist on estrogen receptor in bone tissue → inhibition of [[Bone remodeling|osteoclasts]]
## Indications
- <span style="background:rgba(240, 200, 0, 0.2)">Prophylaxis of [[breast cancer|breast cancer]] in high-risk patients</span>
- [[Osteoporosis|Osteoporosis]] in older patients (if bisphosphonates are contraindicated)
## Side effects
- <span style="background:rgba(240, 200, 0, 0.2)">↓ Risk of [[endometrial cancer|endometrial cancer]] and uterine sarcoma</span>
# Clomiphene
---
## Mechanism of action
- <span style="background:rgba(240, 200, 0, 0.2)">Blocks hypothalamic estrogen receptors, thereby inhibiting negative feedback and increasing release of FSH and LH to trigger ovulation</span>
## Indications
- Infertility (for ovulation induction)
## Side effects